Mapping the journey of transition: a single-center study of 170 childhood-onset GH deficiency patients

Objective To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP). Design Single- center, retrospective study was performed on 170 consecutive COGHD patients (age 19.2 ± 2.0 years, rang...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Endocrine Connections Ročník 10; číslo 8; s. 935 - 946
Hlavní autori: Doknic, Mirjana, Stojanovic, Marko, Soldatovic, Ivan, Milenkovic, Tatjana, Zdravkovic, Vera, Jesic, Maja, Todorovic, Sladjana, Mitrovic, Katarina, Vukovic, Rade, Miljic, Dragana, Savic, Dragan, Milicevic, Mihajlo, Stanimirovic, Aleksandar, Bogosavljevic, Vojislav, Pekic, Sandra, Manojlovic-Gacic, Emilija, Djukic, Aleksandar, Grujicic, Danica, Petakov, Milan
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Bristol Bioscientifica Ltd 01.08.2021
Bioscientifica
Predmet:
ISSN:2049-3614, 2049-3614
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Objective To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP). Design Single- center, retrospective study was performed on 170 consecutive COGHD patients (age 19.2 ± 2.0 years, range 16–25) transferred after growth completion from two pediatric clinics to the adult endocrine unit. Two separate analyses were performed: (i) cross-sectional analysis of hormonal status, metabolic parameters, BC, and BMD at first evaluation after transfer from pediatrics to the adult department; (ii) longitudinal analysis of BC and BMD dynamics after 3 years of GH replacement therapy (rhGH) in TP. Results COGHD was of a congenital cause (CONG) in 50.6% subjects, tumor-related (TUMC) in 23.5%, and idiopathic (IDOP) in 25.9%. TUMC patients had increased insulin and lipids levels (P < 0.01) and lower Z score at L-spine (P < 0.05) compared to CONG and IDOP groups. Patients treated with rhGH in childhood demonstrated lower fat mass and increased BMD compared to the rhGH-untreated group (P < 0.01). Three years of rhGH after growth completion resulted in a significant increase in lean body mass (12.1%) and BMD at L-spine (6.9%), parallel with a decrease in FM (5.2%). Conclusion The effect of rhGH in childhood is invaluable for metabolic status, BC, and BMD in transition to adulthood. Tumor-related COGHD subjects are at higher risk for metabolic abnormalities, alteration of body composition, and decreased BMD, compared to those with COGHD of other causes. Continuation of rhGH in transition is important for improving BC and BMD in patients with persistent COGHD.
AbstractList Objective: To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP). Design: Single- center, retrospective study was performed on 170 conse cutive COGHD patients (age 19.2 ± 2.0 years, range 16–25) transferred after growth completion from two pediatric clinics to the adult endocrine unit. Two separate analyses were performed: (i) cross-sectional analysis of hormonal status, metabolic parameters, BC, and BMD at first evaluation after transfer from pediatrics to the adult dep artment; (ii) longitudinal analysis of BC and BMD dynamics after 3 years of GH replacement therapy (rhGH) in TP. Results: COGHD was of a congenital cause (CONG) in 50.6% subjects, tumo r-related (TUMC) in 23.5%, and idiopathic (IDOP) in 25.9%. TUMC patients had increased insulin and lipids levels (P < 0.01) and lower Z score at L-spine (P < 0.05) compared to CONG and IDOP groups. Patients treated with rhGH in childhood demonstrat ed lower fat mass and increased BMD compared to the rhGH-untreated group (P < 0.01). Three years of rhGH after growth completion resulted in a significant increase in le an body mass (12.1%) and BMD at L-spine (6.9%), parallel with a decrease in FM (5.2%). Conclusion: The effect of rhGH in childhood is invaluable for metabolic sta tus, BC, and BMD in transition to adulthood. Tumor-related COGHD subjects are at higher risk for metabolic abnormalities, alteration of body composition, and decreased BMD, compared to those with COGHD of other causes. Continuation of rhGH in transition is important for improving BC and BMD in patients with persistent COGHD.
Objective To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP). Design Single- center, retrospective study was performed on 170 consecutive COGHD patients (age 19.2 ± 2.0 years, range 16–25) transferred after growth completion from two pediatric clinics to the adult endocrine unit. Two separate analyses were performed: (i) cross-sectional analysis of hormonal status, metabolic parameters, BC, and BMD at first evaluation after transfer from pediatrics to the adult department; (ii) longitudinal analysis of BC and BMD dynamics after 3 years of GH replacement therapy (rhGH) in TP. Results COGHD was of a congenital cause (CONG) in 50.6% subjects, tumor-related (TUMC) in 23.5%, and idiopathic (IDOP) in 25.9%. TUMC patients had increased insulin and lipids levels (P < 0.01) and lower Z score at L-spine (P < 0.05) compared to CONG and IDOP groups. Patients treated with rhGH in childhood demonstrated lower fat mass and increased BMD compared to the rhGH-untreated group (P < 0.01). Three years of rhGH after growth completion resulted in a significant increase in lean body mass (12.1%) and BMD at L-spine (6.9%), parallel with a decrease in FM (5.2%). Conclusion The effect of rhGH in childhood is invaluable for metabolic status, BC, and BMD in transition to adulthood. Tumor-related COGHD subjects are at higher risk for metabolic abnormalities, alteration of body composition, and decreased BMD, compared to those with COGHD of other causes. Continuation of rhGH in transition is important for improving BC and BMD in patients with persistent COGHD.
To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP).OBJECTIVETo analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP).Single- center, retrospective study was performed on 170 consecutive COGHD patients (age 19.2 ± 2.0 years, range 16-25) transferred after growth completion from two pediatric clinics to the adult endocrine unit. Two separate analyses were performed: (i) cross-sectional analysis of hormonal status, metabolic parameters, BC, and BMD at first evaluation after transfer from pediatrics to the adult department; (ii) longitudinal analysis of BC and BMD dynamics after 3 years of GH replacement therapy (rhGH) in TP.DESIGNSingle- center, retrospective study was performed on 170 consecutive COGHD patients (age 19.2 ± 2.0 years, range 16-25) transferred after growth completion from two pediatric clinics to the adult endocrine unit. Two separate analyses were performed: (i) cross-sectional analysis of hormonal status, metabolic parameters, BC, and BMD at first evaluation after transfer from pediatrics to the adult department; (ii) longitudinal analysis of BC and BMD dynamics after 3 years of GH replacement therapy (rhGH) in TP.COGHD was of a congenital cause (CONG) in 50.6% subjects, tumor-related (TUMC) in 23.5%, and idiopathic (IDOP) in 25.9%. TUMC patients had increased insulin and lipids levels (P < 0.01) and lower Z score at L-spine (P < 0.05) compared to CONG and IDOP groups. Patients treated with rhGH in childhood demonstrated lower fat mass and increased BMD compared to the rhGH-untreated group (P < 0.01). Three years of rhGH after growth completion resulted in a significant increase in lean body mass (12.1%) and BMD at L-spine (6.9%), parallel with a decrease in FM (5.2%).RESULTSCOGHD was of a congenital cause (CONG) in 50.6% subjects, tumor-related (TUMC) in 23.5%, and idiopathic (IDOP) in 25.9%. TUMC patients had increased insulin and lipids levels (P < 0.01) and lower Z score at L-spine (P < 0.05) compared to CONG and IDOP groups. Patients treated with rhGH in childhood demonstrated lower fat mass and increased BMD compared to the rhGH-untreated group (P < 0.01). Three years of rhGH after growth completion resulted in a significant increase in lean body mass (12.1%) and BMD at L-spine (6.9%), parallel with a decrease in FM (5.2%).The effect of rhGH in childhood is invaluable for metabolic status, BC, and BMD in transition to adulthood. Tumor-related COGHD subjects are at higher risk for metabolic abnormalities, alteration of body composition, and decreased BMD, compared to those with COGHD of other causes. Continuation of rhGH in transition is important for improving BC and BMD in patients with persistent COGHD.CONCLUSIONThe effect of rhGH in childhood is invaluable for metabolic status, BC, and BMD in transition to adulthood. Tumor-related COGHD subjects are at higher risk for metabolic abnormalities, alteration of body composition, and decreased BMD, compared to those with COGHD of other causes. Continuation of rhGH in transition is important for improving BC and BMD in patients with persistent COGHD.
Author Vukovic, Rade
Bogosavljevic, Vojislav
Stojanovic, Marko
Mitrovic, Katarina
Jesic, Maja
Djukic, Aleksandar
Grujicic, Danica
Doknic, Mirjana
Zdravkovic, Vera
Pekic, Sandra
Milenkovic, Tatjana
Milicevic, Mihajlo
Savic, Dragan
Petakov, Milan
Soldatovic, Ivan
Miljic, Dragana
Manojlovic-Gacic, Emilija
Todorovic, Sladjana
Stanimirovic, Aleksandar
AuthorAffiliation University Children’s Clinic, Belgrade, Serbia
Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Institute of Medical Statistics and Informatics, Belgrade, Serbia
Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia
AuthorAffiliation_xml – name: Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– name: Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia
– name: Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia
– name: Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
– name: University Children’s Clinic, Belgrade, Serbia
– name: Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
– name: Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– name: Institute of Medical Statistics and Informatics, Belgrade, Serbia
Author_xml – sequence: 1
  givenname: Mirjana
  surname: Doknic
  fullname: Doknic, Mirjana
  email: mirjanadoknic@gmail.com
  organization: Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 2
  givenname: Marko
  surname: Stojanovic
  fullname: Stojanovic, Marko
  organization: Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 3
  givenname: Ivan
  surname: Soldatovic
  fullname: Soldatovic, Ivan
  organization: Institute of Medical Statistics and Informatics, Belgrade, Serbia
– sequence: 4
  givenname: Tatjana
  surname: Milenkovic
  fullname: Milenkovic, Tatjana
  organization: Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia
– sequence: 5
  givenname: Vera
  surname: Zdravkovic
  fullname: Zdravkovic, Vera
  organization: University Children’s Clinic, Belgrade, Serbia
– sequence: 6
  givenname: Maja
  surname: Jesic
  fullname: Jesic, Maja
  organization: University Children’s Clinic, Belgrade, Serbia
– sequence: 7
  givenname: Sladjana
  surname: Todorovic
  fullname: Todorovic, Sladjana
  organization: Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia
– sequence: 8
  givenname: Katarina
  surname: Mitrovic
  fullname: Mitrovic, Katarina
  organization: Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia
– sequence: 9
  givenname: Rade
  orcidid: 0000-0002-1592-4105
  surname: Vukovic
  fullname: Vukovic, Rade
  organization: Mother and Child Health Care Institute of Serbia ‘Dr Vukan Cupic’, Belgrade, Serbia
– sequence: 10
  givenname: Dragana
  surname: Miljic
  fullname: Miljic, Dragana
  organization: Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 11
  givenname: Dragan
  surname: Savic
  fullname: Savic, Dragan
  organization: Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
– sequence: 12
  givenname: Mihajlo
  surname: Milicevic
  fullname: Milicevic, Mihajlo
  organization: Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
– sequence: 13
  givenname: Aleksandar
  surname: Stanimirovic
  fullname: Stanimirovic, Aleksandar
  organization: Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
– sequence: 14
  givenname: Vojislav
  surname: Bogosavljevic
  fullname: Bogosavljevic, Vojislav
  organization: Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
– sequence: 15
  givenname: Sandra
  surname: Pekic
  fullname: Pekic, Sandra
  organization: Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 16
  givenname: Emilija
  surname: Manojlovic-Gacic
  fullname: Manojlovic-Gacic, Emilija
  organization: Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 17
  givenname: Aleksandar
  surname: Djukic
  fullname: Djukic, Aleksandar
  organization: Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
– sequence: 18
  givenname: Danica
  surname: Grujicic
  fullname: Grujicic, Danica
  organization: Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
– sequence: 19
  givenname: Milan
  surname: Petakov
  fullname: Petakov, Milan
  organization: Faculty of Medicine, University of Belgrade, Belgrade, Serbia
BookMark eNp9kV9rFDEUxQep2Fr74ifIowij-Z-MD4Isa1uo-KLPITO5s5tlNhmTrLDf3kx3BStiXnLJPed3k5yXzUWIAZrmNcHviGD4_XrVUtJiqviz5opi3rVMEn7xR33Z3OS8w3VpIjXDL5pLxqnoJNdXzfjFzrMPG1S2gHbxkAIcURxRSTZkX3wMH5BFuSomaAcIBRLK5eAeRURhNGz95LYxujaGDAXd3iEHox88hOGIZltqUfKr5vlopww35_26-f55_W111z58vb1ffXpoey5paS04YEp2fOi0YlRizp1TneCgad9RwKOjo8ZMD7yvLcpgVLJ3io0SE0pGdt3cn7gu2p2Zk9_bdDTRevN4ENPG2FT8MIGxQgjdAWaYyMpimimhBXCncJ0OorI-nljzod-DWx6f7PQE-rQT_NZs4k-jOdWYkgp4cwak-OMAuZi9zwNMkw0QD9lQIYhQnRSLFJ-kQ4o5JxjN4Itdvr-S_WQINkvaZr0ylJgl7Wp5-5fl983-KT7zex_zkk3xNSP7P8svOSS5qQ
CitedBy_id crossref_primary_10_3390_jcm13154307
crossref_primary_10_3389_fendo_2024_1459998
crossref_primary_10_3390_ijms251910313
ContentType Journal Article
Copyright The authors
The authors 2021 The authors
Copyright_xml – notice: The authors
– notice: The authors 2021 The authors
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1530/EC-21-0274
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Acceso a contenido Full Text - Doaj
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate COGHD patients in transition period
M Doknic et al
EISSN 2049-3614
EndPage 946
ExternalDocumentID oai_doaj_org_article_a55589e0301644d3837585e4d70c98e5
PMC8428021
10_1530_EC_21_0274
GroupedDBID 53G
5VS
AAFZV
ABLYK
ABSQV
ADBBV
AIPOO
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
DIK
EBS
EE-
F9R
FRJ
GROUPED_DOAJ
GX1
INIJC
KQ8
M48
M~E
OK1
RHF
RPM
TBS
AAKMT
AAYXX
CITATION
H13
PGMZT
7X8
5PM
ID FETCH-LOGICAL-b462t-aede37694c987326044dd7954e82b92e0fd2f8038c4b44d23ef76bd73f60121f3
IEDL.DBID DOA
ISICitedReferencesCount 4
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000689728200010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2049-3614
IngestDate Fri Oct 03 12:45:29 EDT 2025
Thu Aug 21 14:14:29 EDT 2025
Fri Sep 05 13:10:33 EDT 2025
Tue Nov 18 22:28:36 EST 2025
Sat Nov 29 03:17:17 EST 2025
Tue May 07 03:03:13 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords bone mineral density
COGHD
transition period
body composition
metabolism
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b462t-aede37694c987326044dd7954e82b92e0fd2f8038c4b44d23ef76bd73f60121f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1592-4105
OpenAccessLink https://doaj.org/article/a55589e0301644d3837585e4d70c98e5
PMID 34259648
PQID 2551579651
PQPubID 23479
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_a55589e0301644d3837585e4d70c98e5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8428021
proquest_miscellaneous_2551579651
crossref_citationtrail_10_1530_EC_21_0274
crossref_primary_10_1530_EC_21_0274
bioscientifica_primary_10_1530_EC_21_0274
PublicationCentury 2000
PublicationDate 2021-08-01
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Bristol
PublicationPlace_xml – name: Bristol
PublicationTitle Endocrine Connections
PublicationYear 2021
Publisher Bioscientifica Ltd
Bioscientifica
Publisher_xml – name: Bioscientifica Ltd
– name: Bioscientifica
SSID ssj0000816830
Score 2.1946197
Snippet Objective To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the...
To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition...
Objective: To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the...
SourceID doaj
pubmedcentral
proquest
crossref
bioscientifica
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 935
SubjectTerms body composition
bone mineral density
coghd
metabolism
transition period
Title Mapping the journey of transition: a single-center study of 170 childhood-onset GH deficiency patients
URI http://dx.doi.org/10.1530/EC-21-0274
https://www.proquest.com/docview/2551579651
https://pubmed.ncbi.nlm.nih.gov/PMC8428021
https://doaj.org/article/a55589e0301644d3837585e4d70c98e5
Volume 10
WOSCitedRecordID wos000689728200010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Acceso a contenido Full Text - Doaj
  customDbUrl:
  eissn: 2049-3614
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000816830
  issn: 2049-3614
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2049-3614
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000816830
  issn: 2049-3614
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELWg4gASCCiILVAZgZA4WE1sZ21zK6stvbTiANLeLDsZw0ptFu2mSL3025lxstVGQnDhkkM8SqyZceaNPXnD2DsAk1KTaMfdKaGhlCKAK0RUujFB1q4KNjebMOfndrFwX3ZafVFNWE8P3CvuKBAhlQNC7hi6G0qoEOECPqmonYXMXoqoZyeZyt9gaieRG41IhMBCYRAauEkrVRzNZ0KWdHqpH7CHcdmzRubSnHF4yiz-I-g5LpzciUQnj9mjAULy437qT9gdaJ-y_eMW0-fLa_6e56LOvFu-z9JZIAKG7xxxHs9-A9d8lXhHISpXa33kgdN-wQUIeh-seWacJaHSFLzeUh8LKrvu-OdT3gCxTtAvm3xgZd08Y99O5l9np2JorSCinsoO7dEAflqcRh0aRHAFqrYxrtJgZXQSitTIZAtlax1xSCpIZhobo9KUSOCSes722lULLxjXlSujSdLg0tcxhhAxRVGYWNsiIngxE_ZhrGL_s-fR8JR_oDn8fOZl6ckcKLvVvq8HjnJqlXHxR9m3t7J_e-InMuKtBLFp5xvoY37wMf8vH5uwN1sX8Lj66EgltLC62nhMyEr6m7cqJ8yMfGP0xvFIu_yRebwtpn4IsQ7-xxRfsvuSqm1yaeIrttetr-A1u1f_6pab9SG7axb2MC8RvJ7dzH8Dp6sS0g
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mapping+the+journey+of+transition%3A+a+single-center+study+of+170+childhood-onset+GH+deficiency+patients&rft.jtitle=Endocrine+Connections&rft.au=Doknic%2C+Mirjana&rft.au=Stojanovic%2C+Marko&rft.au=Soldatovic%2C+Ivan&rft.au=Milenkovic%2C+Tatjana&rft.date=2021-08-01&rft.pub=Bioscientifica+Ltd&rft.eissn=2049-3614&rft.volume=10&rft.issue=8&rft.spage=935&rft.epage=946&rft_id=info:doi/10.1530%2FEC-21-0274&rft_id=info%3Apmid%2F34259648&rft.externalDocID=PMC8428021
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2049-3614&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2049-3614&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2049-3614&client=summon